Jump Financial »

Halozyme Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.3M 58k 57.24
2022-12-31 $471k 8.3k 56.90
2022-06-30 $2.9M 65k 44.06
2021-06-30 $1.8M 40k 44.56
2020-12-31 $214k 5.0k 42.70

More positions owned by Jump Financial

SPDR S&P 500 ETF Trust Etf (SPY)
iShares Core S&P 500 ETF Etf (IVV)
Tesla Common Stock (TSLA)
Vanguard S&P 500 ETF Etf (VOO)
iShares 20 Year Treasury Bond ETF Etf (TLT)
Meta Platforms Common Stock (META)
Invesco QQQ Trust Series 1 Etf (QQQ)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Microsoft Corp Common Stock (MSFT)
Intercontinental Exchange Common Stock (ICE)
NVIDIA Corp Common Stock (NVDA)
Berkshire Hathaway Common Stock (BRK.B)
Intel Corp Common Stock (INTC)
Thermo Fisher Scientific Common Stock (TMO)

View all positions for Jump Financial

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Bank of America Corporation
Alliancebernstein
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Invesco
Congress Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics